A 58-year-old male from Delhi with diabetes mellitus presents with fever, dysuria, and flank pain for 3 days. Urine culture grows a gram-negative rod. Urinalysis shows pyuria and bacteriuria. Antibiotic susceptibility testing reveals resistance to ceftriaxone, cefotaxime, and ceftazidime, but susceptibility to carbapenems and fluoroquinolones. ESBL production is confirmed by the double-disk synergy test. The patient is currently on no antibiotics. What is the most appropriate immediate next step in management?

Explanation

## Clinical Context This patient has a symptomatic urinary tract infection (likely pyelonephritis given flank pain and fever) caused by an ESBL-producing gram-negative organism. ESBL-producing bacteria are resistant to third-generation cephalosporins but remain susceptible to carbapenems. ## Why Carbapenems Are the Gold Standard for ESBL Infections **Key Point:** Carbapenems (meropenem, imipenem, ertapenem) are the drugs of choice for serious infections caused by ESBL-producing organisms because they are resistant to hydrolysis by extended-spectrum β-lactamases. **High-Yield:** ESBL enzymes (TEM, SHV, CTX-M variants) have a broad substrate spectrum but cannot efficiently degrade carbapenems due to the β-methyl group at position 1 of the carbapenem ring, which prevents accommodation in the enzyme's active site. ## Management Algorithm ```mermaid flowchart TD A[Symptomatic UTI with ESBL-producing organism]:::outcome A --> B{Severity?}:::decision B -->|Mild/Moderate, oral intake OK| C[Ertapenem 1 g IV daily or oral fluoroquinolone if susceptible]:::action B -->|Severe/Sepsis/Vomiting| D[Meropenem 1 g IV 8-hourly]:::action D --> E[Blood cultures before antibiotics]:::action E --> F[Clinical response in 48-72 hours]:::outcome C --> F ``` **Clinical Pearl:** In this case, the patient has fever, flank pain, and systemic symptoms consistent with pyelonephritis (severe UTI). Meropenem IV is appropriate because: - Oral intake may be compromised due to systemic illness - IV therapy achieves higher renal tissue concentrations - Pyelonephritis requires aggressive initial therapy ## Why Blood Cultures First? **Key Point:** Blood cultures should be obtained BEFORE starting antibiotics in febrile patients with suspected bacteremia (pyelonephritis carries ~20% bacteremia risk). This improves diagnostic yield and guides therapy if resistance patterns differ from urine isolate. ## Dosing in Renal Function Assuming normal renal function (not stated otherwise), meropenem 1 g IV every 8 hours is standard. Adjust if CrCl <50 mL/min. [cite:Harrison 21e Ch 297]